Sudden cardiac death with apparently normal heart: Clinical implications of progress in pathophysiology

Cardiac Electrophysiology Review

Volumn 5, Issue 4, 2001, Pages 394-402

  Chugh, S S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; ERGOMETRINE; FLECAINIDE; PROCAINAMIDE; PROPRANOLOL; PROSTACYCLIN; VASODILATOR AGENT; VERAPAMIL;

ANGIOCARDIOGRAPHY; ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; CORONARY ARTERY SPASM; CORONARY STENT; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; LONG QT SYNDROME; MITRAL VALVE PROLAPSE; OBESITY; PATHOPHYSIOLOGY; SEIZURE; SUDDEN DEATH;

EID: 0035663470     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013254132689     Document Type: Article

References (78)

1. Epidemiology of sudden cardiac death: Population characteristics, conditioning risk factors, and dynamic risk factors
2. Sudden cardiac death with apparently normal heart
3. Survivors of out-of-hospital cardiac arrest with apparently normal heart-need for definition and standardized clinical evaluation
4. Sudden unexpected non-traumatic death in 54 young adults: A 30-year population-based study Am
5. Sudden unexpected death from natural causes in young adults. A review of 275 consecutive autopsied cases
6. The autopsy as a measure of accuracy of the death certificate
7. The cardiac pathology of sudden, unexplained nocturnal death in Southeast Asian refugees
8. Right ventricular cardiomyopathy and sudden death in young people
9. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management parts I and II
10. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management-Part III
11. Congenital deafmutism, prolonged QT interval, syncopal attacks and sudden death
12. Congenital deafmutism, functional heart disease with prolongation of the Q-T interval and sudden death
13. Aritmie cardiache rare dell'eta pediatrica
14. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
15. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
16. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
17. Mutations in the hminK gene cause long QT syndrome and suppress IKs function
18. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
19. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
20. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: Experience in 101 related family members
21. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report
22. Familial cardiomyopathy underlies syndrome of right bundle branch block, ST segment elevation and sudden death
23. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
24. Enhanced Na+ channel intermediate inactivation in brugada syndrome
25. Sodium "Channelopathies" and sudden death: Must you be so sensitive?
26. Cardiac conduction defects associate with mutations in SCN5A
27. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men
28. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts
29. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families
30. Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death
31. The elusive link between LQT3 and Brugada syndrome: The role of flecainide challenge
32. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease
33. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome
34. Low prevalence of coronary artery spasm in patients with normal coronary angiograms and unexplained ventricular fibrillation
35. Cardiac arrest associated with coronary artery spasm
36. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm
37. Role of electrophysiologic testing and coronary spasm provocation test in survivors of cardiac arrest
38. High prevalence of coronary artery spasm in survivors of cardiac arrest with no apparent heart disease
39. Sudden death from coronary vasospasm: Persistent angina predicts recurrence
40. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography
41. Long-term prognosis of patients with variant angina
42. International registry for drug-induced arrhythmias
43. Low penetrance in the long-QT syndrome: Clinical impact
44. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: Classification, differential diagnosis, and implications for therapy
45. Sudden arrhythmic death without overt heart disease
46. Idiopathic ventricular fibrillation in out-of-hospital cardiac arrest survivors
47. Ventricular fibrillation in patients without significant structural heart disease: A multicenter experience with implantable cardioverter-defibrillator therapy
48. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias
49. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients
50. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia
51. Arterial hypertension and cardiac arrhythmias
52. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy
53. Hypertrophy and Arrhythmias
54. Significant incidence of unexplained myocardial interstitial fibrosis: Can it explain sudden cardiac death?
55. Sudden cardiac death in mitral valve prolapse response
56. Sudden death in primary mitral valve prolapse
57. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions
58. Epilepsy: Frequency, causes and consequences
59. Risk factors for sudden unexpected death in epilepsy: A case-control study
60. Cause-specific mortality in epilepsy: A cohort study of more than 9,000 patients once hospitalized for epilepsy
61. Cohort study of incidence of sudden unexplained death in persons with seizure disorder treated with antiepileptic drugs in Saskatchewan, Canada
62. Incidence and risk factors in sudden unexpected death in epilepsy: A prospective cohort study
63. Patients with epilepsy who die suddenly have cardiac disease
64. Autonomic dysfunction in epilepsy: Characterization of autonomic cardiac neural discharge associated with pentylenetetrazol-induced epileptogenic activity
65. Review of autonomic dysfunction, cardiac arrhythmias, and epileptogenic activity
66. Mortality of severely obese subjects
67. Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity
68. Sudden death as a result of heart disease in morbid obesity
69. Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity
70. The heart in massive (more than 300 pounds or 136 kilograms) obesity: Analysis of 12 patients studied at necropsy
71. Assessment of cardiac autonomic control by heart period variability in patients with early-onset familial obesity
72. Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia
73. Syncope and ventricular tachycardia in patients with ventricular preexcitation
74. Ventricular fibrillation in the Wolff-Parkinson-White syndrome
75. Nonventricular arrhythmias as precursors of ventricular fibrillation in patients with out-of-hospital cardiac arrest
76. Characteristics of atrioventricular conduction and the spectrum of arrhythmias in lown-ganong-levine syndrome
77. Patients with supraventricular tachycardia presenting with aborted sudden death: Incidence, mechanism and long-term follow-up
78. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, Part I